This paper reviews literature on passively transferred maternal antibodies against measles
in infants. The amount and decay of these antibodies can be a result of changing patterns in …

Background Maternal antibodies, transported over the placenta during pregnancy,
contribute to the protection of infants from infectious diseases during the first months of life …

Evaluation of: Leuridan E, Hens N, Hutse V et al. Early waning of maternal measles
antibodies in era of measles elimination: longitudinal study. Br. Med. J. 340, c1626 (2010) …

The optimal age for measles vaccination is an important health issue, since maternal
antibodies may neutralize the vaccine antigen before a specific immune response develops …

As infants lose maternally derived antibody, they experience a period when antibody levels
are insufficient to protect against measles yet may interfere with immunization. In Kangaba …

Background Many measles cases in Tianjin, China, occur in infants whose mothers were
born after widespread vaccination programs. We assessed age-specific decreases in …

The anti-measles virus (MV) antibody titers in the sera of vaccinees and naturally infected
individuals of different age groups were measured to help assess the efficacy of the current …

A standard treatment with a dose of 2 g/kg of intravenous immune globulin (IVIG) is
sometimes ineffective in some patients with Kawasaki disease (KD), who are commonly …

Objective: To establish the most appropriate age ranges for the use of human normal
immunoglobulin and MMR vaccine as postexposure prophylaxis. Design: Review of …

Die Elimination der Masern und Röteln bis 2015 ist erklärtes Ziel der Europäische Region
der WHO (WHO/Europa). Molekular-epidemiologische Studien tragen dazu bei, Fortschritte …